2022 Á¦9ȸ ´ëÇѳ²¼º°úÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ °øµ¿½ÉÆ÷Áö¾ö : 2022-10-21±³À°ÀÏÀÚ : 2022-10-21
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ)
±³À°ÁÖÁ¦ :
2022 Á¦9ȸ ´ëÇѳ²¼º°úÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ °øµ¿½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѳ²¼º°úÇÐȸ
´ã´çÀÚ : ¹Ú¼ºÀº
¿¬¶ôó : 02-6956-7989
À̸ÞÀÏ :
gaonpco@gaonpco.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¿ï»ê±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ï - Àü¹®ÀÇ:2¸¸¿ø, ÀÌ¿Ü 1¸¸¿ø ÇöÀåµî·Ï - Àü¹®ÀÇ:3¸¸¿ø, ÀÌ¿Ü 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 13:40~14:00 Diagnosis of Premature Ejaculation ÃÖ¿ì¼®(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 14:00~14:20 Treatment of Metastatic Prostate Cancer ÇÏÀ±¼®(°æºÏÀÇ´ë)
Åä·Ð 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 14:20~14:30 Q & A Á¶¹®±â(¿øÀÚ·ÂÀÇÇпø)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 14:30~14:45 TRT in Patients with BPH/LUTS ¾çÈñÁ¶(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 14:45~15:00 TRT in Patients with Prostate Cancer ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 15:00~15:15 TRT in Patients with Cardiovascular Disease À̵¿¼·(°¡Å縯ÀÇ´ë)
Åä·Ð 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 15:15~15:30 Panel Discussion °íÁؼº(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 15:30~15:50 Coffee Break ()
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 15:50~16:05 Optimal Strategy for Prostate Biopsy ¹ÚÁ¾¿í(¿øÀÚ·ÂÀÇÇпø)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 16:05~16:20 Medical Therapy for Peyronie's Disease ±èÀçÇå(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 16:20~16:35 Focal Therapy for Prostate Cancer ÀÌÇйÎ(¼¿ïÀÇ´ë)
Åä·Ð 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 16:35~16:50 Panel Discussion ¹®°æÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 16:50~17:05 Should we do PSA screening, biopsy and prostate cancer treatment in elderly men? ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 17:05~17:20 Patient with Extremely Large Prostate, Who Want to Preserve Sexual Function Á¤µÎ¿ë(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 17:20~17:35 Asymptomatic Young Man with Low Testosterone ±è¼öÁø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 17:35~17:50 Patient with Erectile Dysfunction, Who Failed PDE5I, Intracavernous Injection and PPI ¾È¼øÅÂ(°í·ÁÀÇ´ë)
Åä·Ð 10-21 ·Ôµ¥È£ÅÚ ¿ï»ê Å©¸®½ºÅ»º¼·ë (2Ãþ) 17:50~18:10 Panel Discussion ÇÑÁØÇö(ÇѸ²ÀÇ´ë)